In vitro and in vivo antibiofilm activity of a coral associated actinomycete against drug resistant Staphylococcus aureus biofilms

Biofouling

Volumn 26, Issue 6, 2010, Pages 711-717

  Bakkiyaraj, Dhamodharan ^a   Pandian, ShunmugiahThevar Karutha ^a  

^a ALAGAPPA UNIVERSITY   (India)

Author keywords

Antibiofilm agents; CLSM; Coral associated actinomycetes; MRSA; S. Aureus; Staphylococcal biofilms

Indexed keywords

EID: 79952108288     PISSN: 08927014     EISSN: 10292454     Source Type: Journal    
DOI: 10.1080/08927014.2010.511200     Document Type: Article

References (34)

1. Baldassarri L, Creti R, Recchia S, Imperi M, Facinelli B, Giovanetti E, Pataracchia M, Alfarone G, Orefici G. 2006. Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation. J Clin Microbiol 44: 2721-2727.
2. Brady RA, Leid JG, Camper AK, Costerton JW, Shirtliff ME. 2006. Identification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection. Infect Immun 74: 3415-3426.
3. Branda SS, Vik A, Friedman L, Kolter R. 2005. Biofilms: the matrix revisited. Trends Microbiol 13: 20-26.
4. Dobretsov S, Dahms H-U, Qian P-Y. 2006. Inhibition of biofouling by marine microorganisms and their metabolites. Biofouling 22: 43-54.
5. Eccleston GP, Brooks PR, Kurtboke DI. 2008. The occurrence of bioactive micromonosporae in aquatic habitats of the Sunshine Coast in Australia. Mar Drugs 6: 243-261.
6. El-Gendy MM, Hawas UW, Jaspars M. 2008. Novel bioactive metabolites from a marine derived bacterium Nocardia sp. ALAA 2000. J Antibiot 61: 379-386.
7. Faulkner DJ. 2002. Marine natural products. Nat Prod Rep 19: 1-48.
8. Fernandez-Hidalgo N, Gavalda J, Almirante B, Martin MT, Onrubia PL, Gomis X, Pahissa A. 2010. Evaluation of linezolid, vancomycin, gentamicin and ciprofloxacin in a rabbit model of antibiotic-lock technique for Staphylococcus aureus catheter-related infection. J Antimicrob Chemother 65: 525-530.
9. Fujimura S, Sato T, Kikuchi T, Zaini J, Gomi K, Watanabe A. 2009. Efficacy of clarithromycin plus vancomycin in mice with implant-related infection caused by biofilmforming Staphylococcus aureus. J Orthop Sci 14: 658-661.
10. Gilbert P, Allison DG, McBain AJ. 2002. Biofilms in vitro and in vivo: do singular mechanisms imply crossresistance? J Appl Microbiol 92(Suppl): 98S-110S.
11. Hanaki H, Labischinski H, Inaba Y, Kondo N, Murakami H, Hiramatsu K. 1998. Increase in glutamine-nonamidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50. J Antimicrob Chemother 42: 315-320.
12. Hertiani T, Edrada-Ebel R, Ortlepp S, van Soest RW, de Voogd NJ, Wray V, Hentschel U, Kozytska S, Muller WE, Proksch P. 2010. From anti-fouling to biofilm inhibition: new cytotoxic secondary metabolites from two Indonesian Agelas sponges. Bioorg Med Chem 18: 1297-1311.
13. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40: 135-136.
14. Imada C. 2005. Enzyme inhibitors and other bioactive compounds from marine actinomycetes. Antonie Leeuwenhoek 87: 59-63.
15. Jansen WTM, Bolm M, Balling R, Chhatwal GS, Schnabel R. 2002. Hydrogen peroxide-mediated killing of Caenorhabditis elegans by Streptococcus pyogenes. Infect Immun 70: 5202-5207.
16. LoVetri K, Madhyastha S. 2010. Antimicrobial and antibiofilm activity of quorum sensing peptides and peptide analogues against oral biofilm bacteria. Methods Mol Biol 618: 383-392.
17. Mainardi JL, Shlaes DM, Goering RV, Shlaes JH, Acar JF, Goldstein FW. 1995. Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus. J Infect Dis 171: 1646-1650.
18. Mikhailov VV, Kuznetsova TA, Eliakov GB. 1995. Bioactive compounds from marine actinomycetes. Bioorg Khim 21: 3-8.
19. Neoh HM, Hori S, Komatsu M, Oguri T, Takeuchi F, Cui L, Hiramatsu K. 2007. Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections. Ann Clin Microbiol Antimicrob 6: 13.
20. Nithya C, Aravindraja C, Pandian SK. 2010. Bacillus pumilus of Palk Bay origin inhibits quorum-sensing-mediated virulence factors in Gram-negative bacteria. Res Microbiol 161: 293-304.
21. Nithyanand P, Pandian SK. 2009. Phylogenetic characterization of culturable bacterial diversity associated with the mucus and tissue of the coral Acropora digitifera from the Gulf of Mannar. FEMS Microbiol Ecol 69: 384-394.
22. Novick RP. 2003. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 48: 1429-1449.
23. Ooi N, Miller K, Randall C, Rhys-Williams W, Love W, Chopra I. 2010. XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms. J Antimicrob Chemother 65: 72-78.
24. Rohde H, Burandt EC, Siemssen N, Frommelt L, Burdelski C, Wurster S, Scherpe S, Davies AP, Harris LG, Horstkotte MA, et al. 2007. Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials 28: 1711-1720.
25. Sauer K, Thatcher E, Northey R, Gutierrez AA. 2009. Neutral super-oxidised solutions are effective in killing P. aeruginosa biofilms. Biofouling 25: 45-54.
26. Schillaci D, Petruso S, Raimondi MV, Cusimano MG, Cascioferro S, Scalisi M, La Giglia MA, Vitale M. 2010. Pyrrolomycins as potential anti-staphylococcal biofilms agents. Biofouling 26: 433-438.
27. Selvin J, Shanmughapriya S, Gandhimathi R, Kiran GS, Ravji TR, Natarajaseenivasan K, Hema TA. 2009. Optimization and production of novel antimicrobial agents from sponge associated marine actinomycetes Nocardiopsis dassonvillei MAD08. Appl Microbiol Biotechnol 83: 435-445.
28. Solanki R, Khanna M, Lal R. 2008. Bioactive compounds from marine actinomycetes. Indian J Microbiol 48: 410-431.
29. Stewart PS, Costerton JW. 2001. Antibiotic resistance of bacteria in biofilms. Lancet 358: 135-138.
30. Thenmozhi R, Nithyanand P, Rathna J, Pandian SK. 2009. Antibiofilm activity of coral-associated bacteria against different clinical M serotypes of Streptococcus pyogenes. FEMS Immunol Med Microbiol 57: 284-294.
31. Toté K, Berghe DV, Deschacht M, de Wit K, Maes L, Cos P. 2009. Inhibitory efficacy of various antibiotics on matrix and viable mass of Staphylococcus aureus and Pseudomonas aeruginosa biofilms. Int J Antimicrob Agents 33: 525-531.
32. Valle J, Toledo-Arana A, Berasain C, Ghigo JM, Amorena B, Penades JR, Lasa I. 2003. SarA and not sigmaB is essential for biofilm development by Staphylococcus aureus. Mol Microbiol 48: 1075-1087.
33. Weigel LM, Donlan RM, Shin DH, Jensen B, Clark NC, McDougal LK, Zhu W, Musser KA, Thompson J, Kohlerschmidt D, et al. 2007. High-level vancomycinresistant Staphylococcus aureus isolates associated with a polymicrobial biofilm. Antimicrob Agents Chemother 51: 231-238.
34. Yarwood JM, Bartels DJ, Volper EM, Greenberg EP. 2004. Quorum sensing in Staphylococcus aureus biofilms. J Bacteriol 186: 1838-1850.